Fuzzy, relying on Zenith to save the day seems a long way off seeing that all the Clinical Trials are not into Phase 3. Phase 3 Trials can run for a few years. We need something more immediate.

We will never know why Shawn Lu resigned.

HL converting debentures to common shares may not be all that bad and dethroning DM in the process.  Beats HL taking possession of the IPs. But even that may not be that easy for HL to do when there is the Ori Group and Eastern to run interference. 

Koo